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September 14, 2010:995–9ramingham risk score across age, sex, and ethnic category, and
he Dallas Heart Study, in which CAC scores100 were observed
n a substantial proportion of low-risk patients who would not
therwise have been candidates for statin-based therapy (2,3).
iven the uneasiness on the part of many clinicians about relying
olely on the Framingham risk score (particularly in younger
omen and men and those with strong family histories of
remature CHD), the performance of CAC scoring in low-risk
atients may represent not only a clinical reality but also an
pportunity for improved stratification and reclassification of
HD risk.
Dr. McEvoy and colleagues also suggest that progression of
AC 0 to a higher CAC score may be due to the intermediate
ollow-up period of 1.9 years or interscan variability. Using the
clinically meaningful cutoff” of a 15% increase between CAC
cans they recommend, the relationship of increase in CAC
emains dependent solely on the baseline CAC score. In stepwise
ultivariate analyses, CAC 400 and CAC 600 were the only
redictive factors for CAC rise in both low-risk (hazard ratio: 2.08;
5% confidence interval: 1.29 to 3.35; p  0.003) and
ntermediate-risk (hazard ratio: 1.82; 95% confidence interval: 1.23
o 2.58; p  0.001) patients.
We agree with Dr. McEvoy and colleagues that many questions
elated to the potential effects of lipid-lowering therapies on CAC
emain unanswered, and we agree that CAC  0 holds great
otential for optimizing the classification of asymptomatic pa-
ients. We hope that our findings that demonstrate a 4-year
warranty period” of CAC  0 across all strata of CHD risk will
dd to the foundation of scientific evidence on which future studies
an be based, and in the interim, may inform physicians who use
AC scanning that retesting patients at intervals of 4 years is
nlikely to be helpful.
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n Patients Undergoing
nvasive Management for
cute Coronary Syndromes
ith interest we read the recent report by Sorajja et al. (1),
howing that delaying revascularization with percutaneous coro-
ary intervention (PCI) for 24 h in patients with acute coronary
yndrome was associated with an increased hazard for mortality
nd adverse ischemic outcomes, when compared with intervention
ithin 8 h or 8 to 24 h (1).
This finding was mainly driven by significantly more myocardial
nfarctions (MI) occurring in the delayed intervention group (24 h).
ecause of the natural course of cardiac biomarkers in the setting of
yocardial ischemia, procedure-related myonecrosis with immediate
ntervention is difficult to discern from elevated biomarker levels
efore PCI due to the index event. Thus, the diagnosis of procedure-
elated MI in early PCI is prone to detection bias.
Furthermore, the study had made a rather firm selection of
atients, because 4,491 patients who did not undergo PCI after
iagnostic angiography were left out. We hypothesize that patients
ith mild coronary artery disease underwent early PCI influenced by
he recent symptoms associated with the index event, whereas stabi-
ized patients with mild CAD undergoing delayed angiography did
ot undergo PCI and were excluded from the analysis. The authors
hould have at least reported outcomes by timing of angiography.
Finally, the Kaplan-Meier curves for mortality or MI continue
o diverge up to 30 days and thereafter. Apparently, the risk of
elaying intervention is not limited to an excess risk during the
aiting period, but also extends to the period after the interven-
ion. This observation is suggestive of patient selection for late PCI
ather than of an implicit higher risk of the intervention being
erformed at a later time point. This observation of selection bias
s corroborated by the observation that patients who received PCI
24 h had a worse baseline-risk profile and angiographic charac-
eristics. We note that the authors did not explain the higher death
r MI hazard with delayed intervention.
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